These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4695789)

  • 1. [Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide].
    Wawrzeńczyk B; Zaruski A
    Gruzlica; 1973 Feb; 41(2):177-80. PubMed ID: 4695789
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphazinamide in the treatment of pulmonary tuberculosis].
    Alix Y Alix J; Camps Burón J; Domingo E; Daza M; García-Baquero JM; Lanzón J; Pignatelli F; Alix Trueba A
    Rev Clin Esp; 1967 Dec; 107(5):347-54. PubMed ID: 5618870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Morphazinamide and pulmonary tuberculosis (apropos of 112 cases)].
    Kallos S; Brouillet-Gabriel MT; Dumon JF
    Rev Tuberc Pneumol (Paris); 1968; 32(3):432-6. PubMed ID: 5700028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
    Utkin VV; Zankisova IG; Polishchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1972 Feb; 2():57-8. PubMed ID: 5084744
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies of the therapeutical effects and intolerance levels of morphazinamide in pulmonary tuberculosis].
    Ruiz Benítez G; Bonilla C
    Rev Clin Esp; 1967 Apr; 105(1):28-37. PubMed ID: 5613422
    [No Abstract]   [Full Text] [Related]  

  • 6. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical observations on morphazinamide administered intravenously in pulmonary tuberculosis].
    Durigato S
    G Ital Chemioter; 1965; 12(1):82-98. PubMed ID: 5881989
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of some hematochemical data and of the most important biological indexes of disease and of phase in subjects affected by pulmonary tuberculosis treated with morphazinamide].
    Caltagirone S
    Minerva Med; 1965 Sep; 56(70):2766-71. PubMed ID: 5322265
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
    Boccitto G; Sbampato M; Sternini N
    Ann Ist Carlo Forlanini; 1968; 28(2):126-41. PubMed ID: 5735705
    [No Abstract]   [Full Text] [Related]  

  • 10. [Study of hepatic function of patients with pulmonary tuberculosis treated with morphazinamide].
    Stupenengo RH; Martínez M
    Prensa Med Argent; 1966 Aug; 53(33):1808-11. PubMed ID: 5994109
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs].
    Rözewska M
    G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal transport and blood levels of uric acid during long-term administration of a derivative of pyrazinamide, the morphazinamide].
    Campanini M; Fiocco U; Gambari PF; Baggio B; Borsatti A; Todesco S
    G Clin Med; 1975; 56(9-10):345-62. PubMed ID: 1228051
    [No Abstract]   [Full Text] [Related]  

  • 13. [Metabolism of morphazinamide in patients with pulmonary tuberculosis].
    Zierski M
    Minerva Med; 1965 Sep; 56(70):2759-62. PubMed ID: 5852634
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of morphazinamide in treatment of pulmonary tuberculosis].
    Sanguigno N; Carini A
    Minerva Med; 1965 Sep; 56(71):2927-38. PubMed ID: 5322279
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effects of morphazinamide administered alone or in association in treatment of pulmonary tuberculosis. Observations on 126 treated cases].
    Longarato FJ
    Minerva Med; 1965 Sep; 56(71):2954-61. PubMed ID: 5322284
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of pulmonary tuberculosis with morphazinamide alone and in combination with other antimycobacterial agents].
    Curatolo A; Sacerdoti C; Gandini D
    G Ital Mal Torace; 1966; 20(1):28-32. PubMed ID: 5934393
    [No Abstract]   [Full Text] [Related]  

  • 17. [The antitubercular activity of a pyrazinamide derivative: morphazinamide].
    Grassi C
    Acta Tuberc Pneumol Belg; 1966; 57(3):196-210. PubMed ID: 4862621
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of tuberculosis of children in the age of puberty (isoniazid and morfazinamide)].
    Görgényi-Göttche O; Vass E
    Prax Pneumol; 1968 Apr; 22(4):238-45. PubMed ID: 5303063
    [No Abstract]   [Full Text] [Related]  

  • 19. [Morphazinamide in venous perfusions in the treatment of pulmonary tuberculosis].
    Alves de Souza M
    Schweiz Med Wochenschr; 1966 Jun; 96(25):829-32. PubMed ID: 5987049
    [No Abstract]   [Full Text] [Related]  

  • 20. [Morphazinamide in association with other antimycobacterial drugs in the therapy of pulmonary tuberculosis].
    Moncalvo F; Moreo GG
    Minerva Med; 1965 Sep; 56(70):2810-1. PubMed ID: 5852638
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.